{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:42:49Z","timestamp":1787161369172,"version":"build-2736575974"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,8,11]]},"abstract":"<jats:p>Corticosteroids are sometimes used in inoperable malignant bowel obstruction (MBO) despite limited evidence. The main randomised evidence comes from an old Cochrane review totalling 89 patients demonstrating a non-significant trend towards obstruction resolution and no survival benefit. Subsequent literature consists of retrospective and uncontrolled studies failing to control for spontaneous resolution, disease heterogeneity and concomitant therapies. Dose, duration and outcomes are inconsistently reported. Corticosteroid toxicities are potentially harmful. Overall, there are no high-quality data to support corticosteroids as a standard therapy in MBO. If a clinician wishes to use in selected patients, this should be as a time-limited therapeutic trial framed within the context of uncertainty.<\/jats:p>","DOI":"10.1136\/spcare-2026-006294","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:19Z","timestamp":1787160019000},"page":"spcare-2026-006294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroids in inoperable malignant bowel obstruction: clinical practice based on limited evidence"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-3057","authenticated-orcid":false,"given":"Jason W","family":"Boland","sequence":"first","affiliation":[{"name":"Wolfson Palliative Care Research Centre, University of Hull, Hull, UK"},{"name":"Palliative Medicine, Care Plus Group, Grimsby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-5929","authenticated-orcid":false,"given":"Elaine G","family":"Boland","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026081910200933000_spcare-2026-006294v1.1","doi-asserted-by":"crossref","DOI":"10.21037\/jgo-2025-708","article-title":"Non-surgical management of malignant bowel obstruction: strategies and outcomes in inoperable patients","volume":"17","author":"Escobar Gil","year":"2026","journal-title":"J Gastrointest Oncol"},{"key":"2026081910200933000_spcare-2026-006294v1.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06889-8"},{"key":"2026081910200933000_spcare-2026-006294v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.05.032"},{"key":"2026081910200933000_spcare-2026-006294v1.4","unstructured":"National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Palliat Care 2026. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf"},{"key":"2026081910200933000_spcare-2026-006294v1.5","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000431","article-title":"Use and Outcomes of Dexamethasone in the Management of Malignant Small Bowel Obstruction","volume":"5","author":"Yang","year":"2024","journal-title":"Ann Surg Open"},{"key":"2026081910200933000_spcare-2026-006294v1.6","unstructured":"Boland JW , Boland EG . Malignant bowel obstruction. In: Cherny NI , Kaasa S , Portenoy RK , et al , eds. Oxford textbook of palliative medicine. 7th edn. Oxford University Press, 2026."},{"key":"2026081910200933000_spcare-2026-006294v1.7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091522","article-title":"Malignant Bowel Occlusion: An Update on Current Available Treatments","volume":"17","author":"Neri","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026081910200933000_spcare-2026-006294v1.8","article-title":"Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer","volume":"2000","author":"Feuer","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081910200933000_spcare-2026-006294v1.9","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008361102808"},{"key":"2026081910200933000_spcare-2026-006294v1.10","doi-asserted-by":"publisher","DOI":"10.1191\/026921698666334766"},{"key":"2026081910200933000_spcare-2026-006294v1.11","first-page":"8089","article-title":"Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update","volume":"29","author":"Davis","year":"2021","journal-title":"Support Care Cancer"},{"key":"2026081910200933000_spcare-2026-006294v1.12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpainsymman.2023.09.014","article-title":"Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center","volume":"67","author":"Walter","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2026081910200933000_spcare-2026-006294v1.13","first-page":"2821","article-title":"Efficacy of dexamethasone in the management of malignant small bowel obstruction in advanced epithelial ovarian cancer","volume":"30","author":"Jones","year":"2022","journal-title":"Support Care Cancer"},{"key":"2026081910200933000_spcare-2026-006294v1.14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpainsymman.2017.10.019","article-title":"Practice Patterns of Medications for Patients With Malignant Bowel Obstruction Using a Nationwide Claims Database and the Association Between Treatment Outcomes and Concomitant Use of H2-Blockers\/Proton Pump Inhibitors and Corticosteroids With Octreotide","volume":"55","author":"Minoura","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"2026081910200933000_spcare-2026-006294v1.15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/02692163221122352","article-title":"The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review","volume":"36","author":"Bravington","year":"2022","journal-title":"Palliat Med"},{"key":"2026081910200933000_spcare-2026-006294v1.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289501","article-title":"Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction","volume":"18","author":"Bravington","year":"2023","journal-title":"PLoS One"},{"key":"2026081910200933000_spcare-2026-006294v1.17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpainsymman.2023.09.021","article-title":"Impact of Dosing and Duration of Dexamethasone on Serious Corticosteroid-Related Adverse Events","volume":"67","author":"An","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2026081910200933000_spcare-2026-006294v1.18","first-page":"211","article-title":"High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction","volume":"31","author":"Boland","year":"2023","journal-title":"Support Care Cancer"},{"key":"2026081910200933000_spcare-2026-006294v1.19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/02692163221098005","article-title":"What do we do with all the evidence for symptoms in palliative care?","volume":"36","author":"Boland","year":"2022","journal-title":"Palliat Med"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2026-006294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:22Z","timestamp":1787160022000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2026-006294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":19,"alternative-id":["10.1136\/spcare-2026-006294"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2026-006294","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}